High-throughput Assay to Phenotype Salmonella enterica Typhimurium Association, Invasion, and Replication in Macrophages
August 11th, 2014
11.8K views
A high-throughput assay to in vitro phenotype Salmonella or other bacterial association, invasion, and replication in phagocytic cells with high-throughput capacity was developed. The method was employed to evaluate Salmonella gene knockout mutant strains for their involvements in host-pathogen interactions.
Overview
This study presents a high-throughput assay designed to evaluate the phenotype of Salmonella in phagocytic cells. The method assesses gene knockout mutant strains to understand their roles in host-pathogen interactions.
Key Study Components
Area of Science
- Microbiology
- Cell Biology
- Pathogen-Host Interactions
Background
- Salmonella is a significant pathogen that can invade macrophages.
- Understanding the genetic basis of its pathogenicity is crucial for developing treatments.
- High-throughput methods allow for efficient screening of multiple strains.
- Gene knockout techniques can elucidate the functions of specific genes in invasion and survival.
Purpose of Study
- To identify genes necessary for Salmonella invasion and survival in macrophages.
- To evaluate the in vitro phenotypes of wild type and mutant strains.
- To enhance understanding of Salmonella pathogenesis mechanisms.
Methods Used
- Infection of macrophage cell cultures with Salmonella strains.
- Use of 96-well plates for high-throughput screening.
- Application of Gentamycin to eliminate extracellular bacteria.
- Measurement of colony formation units to assess bacterial replication.
Main Results
- Comparison of mutant strains with wild type revealed differences in invasion and replication.
- Results indicated specific genes involved in Salmonella's ability to survive within macrophages.
- The assay effectively determined the in vitro phenotypes of the strains tested.
- Findings contribute to the understanding of host-pathogen interactions.
Conclusions
- The high-throughput assay is a valuable tool for studying Salmonella pathogenesis.
- Identifying mechanistic genes can inform future therapeutic strategies.
- This method can be adapted for other bacterial studies in phagocytic cells.
Frequently Asked Questions
What is the significance of studying Salmonella?
Salmonella is a major human pathogen, and understanding its mechanisms can lead to better treatments and prevention strategies.
How does the high-throughput assay work?
It allows simultaneous testing of multiple strains in macrophage cultures to evaluate their invasion and replication capabilities.
What role does Gentamycin play in the experiment?
Gentamycin is used to kill extracellular bacteria, ensuring that only intracellular Salmonella are assessed for replication.
Can this method be used for other bacteria?
Yes, the assay can be adapted for studying other bacterial pathogens in phagocytic cells.
What are colony formation units?
Colony formation units (CFUs) are a measure of viable bacterial cells, indicating the ability to grow and replicate.
What insights can be gained from gene knockout studies?
Gene knockout studies help identify specific genes that contribute to pathogenicity and survival in host cells.
Executive Industry Relevance
This high-throughput assay enables systematic evaluation of bacterial virulence genes in phagocytic cells, supporting target validation in anti-infective discovery. By quantifying association, invasion, and intracellular replication in a standardized 96-well format, it reduces variability and increases reproducibility across mutant strains. The method provides quantitative phenotypic data that can inform mechanistic de-risking and prioritization of therapeutic targets early in the discovery pipeline.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Interrogates therapeutic hypotheses by linking specific gene deletions to defects in host-cell association, invasion, or replication.
- Operational Value: Enables parallel testing of wild-type and multiple mutant strains in the same culture dish, improving assay consistency.
- Predictive Value: Generates quantitative CFU data per macrophage to support phenotypic screening and lead identification for anti-virulence strategies.
Screening & Assay Development
- Scientific Value: Produces standardized, quantitative readouts of bacterial survival within phagocytes, enabling reliable compound or genetic perturbation evaluation.
- Operational Value: Uses multichannel pipettes and 96-well plating to increase throughput and precision while minimizing well-to-well variance.
- Scalability: Supports screening of large mutant libraries, as demonstrated with 38 Salmonella deletion mutants, to identify phenotype-genotype correlations.
Translational & Preclinical Research
- Translational Continuity: In vitro phenotypes from the assay were confirmed in vivo, supporting its use in preclinical model validation.
- Mechanistic De-risking: Clarifies roles of specific genes in intracellular survival, reducing ambiguity in target mechanism prior to lead optimization.
- Disease-Relevant System: Uses RAW 264.7 murine macrophages to model Salmonella-host interactions relevant to zoonotic pathogenicity.
Pipeline & Workflow Integration
The assay fits within the early discovery continuum, linking target validation through phenotypic screening to preclinical evaluation by providing quantitative, reproducible data on bacterial-host interactions.
- Discovery Biology: Supports hypothesis testing by measuring how gene knockouts affect bacterial association, invasion, and replication in macrophages.
- Screening: Enables assay readiness through standardized infection, gentamicin protection, and CFU quantification steps compatible with high-throughput formats.
- Analytics: Delivers quantitative dependent variable measurements (CFU per macrophage) that allow comparison across conditions and strains.
- Translational Research: Connects to preclinical continuity through demonstrated correlation between in vitro phenotypes and animal model outcomes.
- Enterprise Reuse: Establishes a reusable platform for studying bacterial pathogenesis in phagocytic cells, adaptable to other intracellular pathogens.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity by isolating the contribution of individual genes to virulence phenotypes in a controlled host-cell system.
- Operational Value: Enhances reproducibility and standardization through synchronized multi-strain testing and reduced assay variance.
- Strategic Value: Improves go/no-go decisions by providing early, quantitative phenotypic data on target engagement in a disease-relevant system.
- Portfolio Impact: Enables risk-adjusted prioritization of targets based on validated roles in host-pathogen interaction mechanisms.
Implementation Considerations
- Requires expertise in bacterial culture, macrophage cell maintenance, and aseptic technique for infection and gentamicin protection steps.
- Depends on access to 96-well plates, multichannel pipettes, incubators, and spectrophotometry for bacterial normalization.
- Necessitates cross-team standardization of MOI, infection duration, and antibiotic concentrations to ensure reproducibility across laboratories.
- Involves adaptation considerations when extending to other bacterial species or host cell types, as noted in the source material.
- Practical limitations include the need for optimization of bacterial OD600 ranges and dilution steps to ensure countable CFU outputs (10–100 colonies per plate).
Biopharma FAQs
Why does null hypothesis testing matter for target validation in this assay?
Null hypothesis testing determines whether observed differences in CFU counts between mutant and wild-type Salmonella strains are statistically significant, supporting confident target validation by distinguishing true phenotypic effects from experimental noise.
How does independent variable isolation fit the discovery pipeline?
Isolating the independent variable (specific gene deletion) allows researchers to attribute changes in association, invasion, or replication directly to that genetic modification, enabling precise target identification in early discovery.
What quantitative dependent variable measurements enable in this assay?
The assay measures colony-forming units (CFUs) per macrophage at defined time points, providing a quantitative dependent variable that enables comparison of bacterial survival across strains and conditions.
Why do replication requirements matter for cross-functional collaboration?
Replication requirements ensure that phenotypic results are consistent across wells, plates, and experiments, which is essential for reliable data sharing between discovery biology, screening, and preclinical teams.
What statistical analysis capabilities are required before implementation?
Implementation requires the ability to perform comparative statistical analysis (e.g., t-tests or ANOVA) on CFU data to determine significant differences between mutant and wild-type strains, supporting data-driven target selection.
